Literature DB >> 23517132

On the origin and diagnostic use of salivary RNA.

H Fábryová1, P Celec.   

Abstract

Saliva as a diagnostic fluid enables non-invasive sampling, which can be performed even by an untrained person. Saliva is, thus, particularly useful for large population screenings, for children, elderly and whenever repeated samplings are needed. Saliva is a plasma filtrate actively modified by the salivary glands. Saliva could replace some routine blood tests in the future. The sources of salivary RNA include oral epithelial cells and oral micro-organisms. Recent developments suggest that using known salivary RNA markers, it is possible to diagnose diseases such as oral carcinoma and other diseases will be added soon. Salivary RNA can be used to identify oral bacteria and to determine the expression of specific genes. On a systemic level, it provides information about the whole oral transcriptome and microbiome. Despite the small amount of salivary RNA, the issues with its isolation have been overcome. Saliva, thus, contains RNA of sufficient quality and quantity for sensitive and specific analyses. Salivary RNA can provide medically relevant information about oral microbiome, oral carcinoma, but also breast and pancreatic cancer and is, thus, a promising tool for future research and clinical diagnostics.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  RNA; RNA markers; diagnosis; saliva

Mesh:

Substances:

Year:  2013        PMID: 23517132     DOI: 10.1111/odi.12098

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  12 in total

1.  A novel saliva-based microRNA biomarker panel to detect head and neck cancers.

Authors:  Carolina Salazar; Rahul Nagadia; Pratibala Pandit; Justin Cooper-White; Nilanjana Banerjee; Nevenka Dimitrova; William B Coman; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2014-08-26       Impact factor: 6.730

2.  Saliva as a sampling source for the detection of leukemic fusion transcripts.

Authors:  Dongmei Chen; Najie Song; Runfang Ni; Jiangning Zhao; Jiasheng Hu; Quanyi Lu; Qingge Li
Journal:  J Transl Med       Date:  2014-11-19       Impact factor: 5.531

3.  The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens.

Authors:  Joanne M Osborne; Ingrid Flight; Carlene J Wilson; Gang Chen; Julie Ratcliffe; Graeme P Young
Journal:  Patient Prefer Adherence       Date:  2018-09-18       Impact factor: 2.711

4.  Salivary LDOC1 is a gender-difference biomarker of oral squamous cell carcinoma.

Authors:  Chung-Ji Liu; Jen-Hao Chen; Shih-Min Hsia; Chiu-Chu Liao; Hui-Wen Chang; Tzong-Ming Shieh; Yin-Hwa Shih
Journal:  PeerJ       Date:  2019-04-09       Impact factor: 2.984

5.  High-Quality and High-Yield RNA Extraction Method From Whole Human Saliva.

Authors:  Vaibhav Gandhi; Mara H O'Brien; Sumit Yadav
Journal:  Biomark Insights       Date:  2020-06-08

6.  Effect of handling and storage conditions and stabilizing agent on the recovery of viral RNA from oral fluid of pigs.

Authors:  T H Jones; V Muehlhauser
Journal:  J Virol Methods       Date:  2013-12-30       Impact factor: 2.014

7.  Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection.

Authors:  Nancy Matic; Aleksandra Stefanovic; Victor Leung; Tanya Lawson; Gordon Ritchie; Lynne Li; Sylvie Champagne; Marc G Romney; Christopher F Lowe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-11-25       Impact factor: 3.267

8.  Loop-mediated isothermal amplification for the detection of SARS-CoV-2 in saliva.

Authors:  Monika Janíková; Július Hodosy; Peter Boor; Boris Klempa; Peter Celec
Journal:  Microb Biotechnol       Date:  2021-01-26       Impact factor: 5.813

9.  Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.

Authors:  Rushdi S Fadhil; Ming Q Wei; Dimitrios Nikolarakos; David Good; Raj G Nair
Journal:  PLoS One       Date:  2020-03-24       Impact factor: 3.240

Review 10.  Role of the microbiome in occurrence, development and treatment of pancreatic cancer.

Authors:  Yicheng Wang; Gang Yang; Lei You; Jinshou Yang; Mengyu Feng; Jiangdong Qiu; Fangyu Zhao; Yueze Liu; Zhe Cao; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2019-12-01       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.